Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Toggle navigation
Contact Us
Subscribe
Promote Your Event
e-Edition
Privacy Policy
Terms of Service
Local Weather
Home Delivery
Submission Forms
News
Local News
The Leader
Heartland News
Sports
Entertainment
Local Events
Multimedia
Photo Galleries
Videos
Obituaries
Classifieds
Real Estate
Property for Rent
Cars & Vehicles
Jobs
Items for Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place an ad
Legals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
44.34
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Feb 2, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,864
Open
44.34
Bid (Size)
44.15 (2)
Ask (Size)
44.28 (3)
Prev. Close
44.34
Today's Range
44.34 - 44.34
52wk Range
41.45 - 56.32
Shares Outstanding
5,606,688,356
Dividend Yield
3.52%
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric
February 02, 2023
The company that remains still has a large pipeline of non-migraine assets.
Via
Investor's Business Daily
Got $1,000? 3 Cheap Stocks To Buy Right Now
February 02, 2023
We may be entering a period of prolonged leadership from undervalued stocks, with these tickers poised to lead the charge.
Via
The Motley Fool
Performance
YTD
-13.50%
-13.50%
1 Month
-13.50%
-13.50%
3 Month
-4.79%
-4.79%
6 Month
-11.07%
-11.07%
1 Year
-17.68%
-17.68%
More News
Read More
This Low-Risk ETF Can Turn $39,000 Into $1 Million in 25 Years
February 02, 2023
Via
The Motley Fool
Pfizer's Sales Could Sink 33% in 2023. Here's Why to Buy the Stock Anyway.
February 02, 2023
Via
The Motley Fool
Novavax Shares Jumped in January While Others Slipped
February 01, 2023
Via
MarketBeat
Exposures
COVID-19
Product Safety
Pfizer (PFE) Q4 2022 Earnings Call Transcript
January 31, 2023
Via
The Motley Fool
Pfizer Beats Q4 Earnings, Issues Underwhelming 2023 Guidance
January 31, 2023
Via
Benzinga
AMD To Rally Over 26%? Here Are 10 Other Analyst Forecasts For Wednesday
February 01, 2023
Via
Benzinga
Pfizer Stock: What the Bulls and Bears are Getting Wrong
February 01, 2023
Via
MarketBeat
S&P 500 Jumps 1.5%, Market Volatility Decreases
February 01, 2023
Via
Benzinga
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
February 01, 2023
Via
The Motley Fool
Dow Surges Over 200 Points; Pfizer Issues Weak Forecast
January 31, 2023
Via
Benzinga
AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff
January 31, 2023
Via
Investor's Business Daily
Waiting for Powell: As Fed Meeting Starts, Investors Parse Mixed Q4 Earnings and Consider What's Next for Rates
January 31, 2023
Via
Benzinga
Sony Scales Back PlayStation VR2 Output, Sam Bankman-Fried Attempted To Regain Control Of FTX, White House Plans To End COVID-19 Emergency: Today's Top Stories
January 31, 2023
Via
Benzinga
Why BioNTech And Moderna Shares Are Falling After Pfizer News
January 31, 2023
Via
Benzinga
Most Important Week Of Earnings Season Is Here — Will S&P 500 Companies Continue Beating Wall Street Estimates?
January 31, 2023
Via
Benzinga
Pfizer Q4 Earnings And Revenues Beat Estimates
January 31, 2023
Via
Talk Markets
The Expected Covid Cliff Is Here For Pfizer — Company Calls For Steep 2023 Declines
January 31, 2023
Via
Investor's Business Daily
Biden Administration Plans To End COVID-19 Public Health Emergency In May
January 31, 2023
Via
Benzinga
4 Discounted Dividend Stocks To Buy In February 2023
January 31, 2023
Via
The Motley Fool
These 3 Healthcare Stocks With Over 3% Dividend Yields Are Recommended By Benzinga's Most Accurate Analysts
January 31, 2023
Via
Benzinga
PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE
January 31, 2023
From
Pfizer Inc.
Via
Business Wire
Nasdaq, S&P Futures Lower As Powell & Team Kick Off 2-Day Fed Meeting: Analyst Says Positive January Harbinger Of Good Times
January 31, 2023
Via
Benzinga
Earnings Scheduled For January 31, 2023
January 31, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.